Background There is growing interest in glutamatergic agents in depression, particularly ketamine, a glutamate N -methyl- d -aspartate (NMDA) receptor antagonist. We aimed to assess the efficacy of ketamine in major depressive episodes. Method We searched EMBASE, PsycINFO, CENTRAL, and Medline fr…